Found: 1
Select item for more details and to access through your institution.
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.
- Published in:
- Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 304, doi. 10.1111/jvh.12648
- By:
- Publication type:
- Article